Furthermore, our study suggests that loss of TMIGD1 in human cancers, which was previously reported in renal and colon cancers [5, 10, 27], could result in the activation of pro-tumorigenic signaling cascades, including the activation of ERM proteins that contribute to tumor progression. The gene discussed is TMIGD1; the disease is cancer.